Question 1

What is the chemical structure that defines sulfonylureas?

Accepted Answer

Sulfonylureas are characterized by a unique sulfonylurea moiety—a sulfonamide group coupled with urea. This distinctive chemical structure defines the drug class and enables their mechanism of action on pancreatic beta cells. The structural composition allows these agents to effectively bind to ATP-sensitive potassium channels and stimulate insulin release.

Question 2

How do sulfonylureas lower blood glucose levels?

Accepted Answer

Sulfonylureas bind to ATP-sensitive potassium channels on pancreatic beta cells, blocking the channel and triggering cell membrane depolarization. This initiates a cellular cascade that stimulates insulin secretion and release. Additionally, these drugs enhance insulin sensitivity in peripheral tissues and reduce hepatic glucose production, collectively lowering blood glucose levels.

Question 3

What are the differences between first-generation and second-generation sulfonylureas?

Accepted Answer

First-generation sulfonylureas include tolbutamide and chlorpropamide, while second-generation agents encompass glyburide, glipizide, and glimepiride. Second-generation drugs are preferred due to their enhanced potency and shorter duration of action. Despite similar mechanisms, second-generation sulfonylureas remain integral in diabetes management due to improved efficacy and pharmacokinetic profiles.

Question 4

What adverse effects are associated with sulfonylurea use?

Accepted Answer

Common adverse effects of sulfonylureas include hypoglycemia, weight gain, and hyperinsulinemia. Hypoglycemia is the most frequent side effect, particularly in elderly patients or those with impaired kidney function. Careful dosage and monitoring are required to mitigate these risks and ensure safe therapeutic outcomes in type 2 diabetes management.

Question 5

When are sulfonylureas prescribed for type 2 diabetes?

Accepted Answer

Sulfonylureas are primarily prescribed when diet and exercise alone fail to manage type 2 diabetes. They can be used as monotherapy or combined with other antidiabetic medications to achieve optimal glycemic control. Their role in diabetes management depends on individual patient factors and response to initial lifestyle interventions.

Question 6

How do sulfonylureas enhance insulin sensitivity beyond pancreatic effects?

Accepted Answer

Beyond stimulating insulin secretion from pancreatic beta cells, sulfonylureas reduce hepatic glucose production and augment peripheral glucose utilization. These extrapancreatic effects contribute to improved glycemic control by decreasing endogenous glucose output and increasing glucose uptake in peripheral tissues, enhancing overall insulin sensitivity.

Question 7

What cellular mechanism triggers insulin release when sulfonylureas block potassium channels?

Accepted Answer

When sulfonylureas block ATP-sensitive potassium channels on pancreatic beta cells, the cell membrane depolarizes. This depolarization allows calcium influx into the cell, triggering a cascade that stimulates insulin secretion and release. This mechanism directly links channel blockade to the therapeutic effect of lowering blood glucose.

Пероральные гипогликемические средства: препараты сульфонилмочевины

Browse More Videos